Resolvins: Endogenously-generated potent painkilling substances and their therapeutic perspectives

Current Neuropharmacology

Volumn 11, Issue 6, 2013, Pages 664-676

  Yoo, Sungjae ^a   Lim, Ji Yeon ^a   Hwang, Sun Wook ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Analgesics; GPRs; Inflammation; Pain; Resolvin; TRP channels

Indexed keywords

ACETYLSALICYLIC ACID; AMPA RECEPTOR; ANALGESIC AGENT; ANKYRIN; ARACHIDONATE 15 LIPOXYGENASE; BRADYKININ; CALCITONIN GENE RELATED PEPTIDE; CYCLOOXYGENASE 2; CYTOCHROME P450; DOCOSAHEXAENOIC ACID; DRUG METABOLITE; ENDORPHIN; FORMYLPEPTIDE RECEPTOR; ICOSAPENTAENOIC ACID; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 6; LIPOXIN; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROSTAGLANDIN; RESOLVIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALLODYNIA; ANALGESIA; ARTICLE; BACTERIAL CLEARANCE; BINDING AFFINITY; BLOOD VESSEL PERMEABILITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DOWN REGULATION; DRUG DEGRADATION; DRUG EFFICACY; FLUID RETENTION; HOMEOSTASIS; HUMAN; HYPERALGESIA; INFLAMMATORY PAIN; JOINT STIFFNESS; NEUTROPHIL; NONHUMAN; PAIN; PERITONITIS; PNEUMONIA; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TH17 CELL; WOUND CLOSURE;

EID: 84899503421     PISSN: 1570159X     EISSN: 18756190     Source Type: Journal    
DOI: 10.2174/1570159X11311060009     Document Type: Article

References (105)

1. Max, M.B.; Stewart, W.F. The molecular epidemiology of pain: a new discipline for drug discovery. Nat. Rev. Drug Discov., 2008, 7, 647-658.
2. Serhan, C.N.; Savill, J. Resolution of inflammation: the beginning programs the end. Nat. Immunol., 2005, 6, 1191-1197.
3. Serhan, C.N.; Hong, S.; Gronert, K.; Colgan, S.P.; Devchand, P.R.; Mirick, G.; Moussignac, R.L. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med., 2002, 196, 1025-1037.
4. Ji, R.R.; Xu, Z.Z.; Strichartz, G.; Serhan, C.N. Emerging roles of resolvins in the resolution of inflammation and pain. Trends Neurosci., 2011, 34, 599-609.
5. Xu, Z.Z.; Zhang, L.; Liu, T.; Park, J.Y.; Berta, T.; Yang, R.; Serhan, C.N.; Ji, R.R. Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. Nat. Med., 2010, 16, 592-597.
6. Bang, S.; Yoo, S.; Yang, T.J.; Cho, H.; Kim, Y.G.; Hwang, S.W. Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple antinociception. Br. J. Pharmacol., 2010, 161, 707-720.
7. Shin, J.; Cho, H.; Hwang, S.W.; Jung, J.; Shin, C.Y.; Lee, S.Y.; Kim, S.H.; Lee, M.G.; Choi, Y.H.; Kim, J.; Haber, N.A.; Reichling, D.B.; Khasar, S.; Levine, J.D.; Oh, U. Bradykinin-12-lipoxygenase-VR1 signaling pathway for inflammatory hyperalgesia. Proc. Natl. Acad. Sci. U. S. A., 2002, 99, 10150-10155.
8. Woo, C.H.; Yoo, M.H.; You, H.J.; Cho, S.H.; Mun, Y.C.; Seong, C.M.; Kim, J.H. Transepithelial migration of neutrophils in response to leukotriene B4 is mediated by a reactive oxygen species-extracellular signal-regulated kinase-linked cascade. J. Immunol., 2003, 170, 6273-6279.
9. Chiu, I.M.; von Hehn, C.A.; Woolf, C.J. Neurogenic inflammation and the peripheral nervous system in host defense and immunopathology. Nat. Neurosci., 2012, 15, 1063-1067.
10. Ji, R.R.; Kohno, T.; Moore, K.A.; Woolf, C.J. Central sensitization and LTP: do pain and emory share similar mechanisms? Trends Neurosci., 2003, 26, 696-705.
11. Tsuda, M.; Inoue, K.; Salter, M.W. Neuropathic pain and spinal microglia: a big problem from molecules in “small” glia. Trends Neurosci., 2005, 28, 101-107.
12. Suter, M.R.; Wen, Y.R.; Decosterd, I.; Ji, R.R. Do glial cells control pain? Neuron Glia Biol., 2007, 3, 255-268.
13. Buckley, C.D.; Gilroy, D.W.; Serhan, C.N.; Stockinger, B.; Tak, P.P. Viewpoint: The resolution of inflammation. Nat. Rev. Immunol., 2013, 13, 59-66.
14. Levy, B.D.; Clish, C.B.; Schmidt, B.; Gronert, K.; Serhan, C.N. Lipid mediator class switching during acute inflammation: signals in resolution. Nat. Immunol., 2001, 2, 612-619.
15. Serhan, C.N.; Clish, C.B.; Brannon, J.; Colgan, S.P.; Chiang, N.; Gronert, K. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J. Exp. Med., 2000, 192, 1197-1204.
16. Hong, S.; Gronert, K.; Devchand, P.R.; Moussignac, R.L.; Serhan, C.N. Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J. Biol. Chem., 2003, 278, 14677-14687.
17. Arita, M.; Bianchini, F.; Aliberti, J.; Sher, A.; Chiang, N.; Hong, S.; Yang, R.; Petasis, N.A.; Serhan, C.N. Stereochemical assignment, anti-inflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J. Exp. Med., 2005, 201, 713-722.
18. Oh, S.F.; Pillai, P.S.; Recchiuti, A.; Yang, R.; Serhan, C.N. Proresolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation. J. Clin. Invest., 2011, 121, 569-581.
19. Okubo, M.; Yamanaka, H.; Kobayashi, K.; Fukuoka, T.; Dai, Y.; Noguchi, K. Expression of leukotriene receptors in the rat dorsal root ganglion and the effects on pain behaviors. Mol. Pain., 2010, 6, 57.
20. Lima-Garcia, J.F.; Dutra, R.C.; da Silva, K.; Motta, E.M.; Campos, M.M.; Calixto, J.B. The precursor of resolvin D series and aspirin-triggered resolvin D1 display anti-hyperalgesic properties in adjuvant-induced arthritis in rats. Br. J. Pharmacol., 2011, 164, 278-293.
21. Samad, T.A.; Moore, K.A.; Sapirstein, A.; Billet, S.; Allchorne, A.; Poole, S.; Bonventre, J.V.; Woolf, C.J. Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature, 2001, 410, 471-475.
22. Connor, K.M.; SanGiovanni, J.P.; Lofqvist, C.; Aderman, C.M.; Chen, J.; Higuchi, A.; Hong, S.; Pravda, E.A.; Majchrzak, S.; Carper, D.; Hellstrom, A.; Kang, J.X.; Chew, E.Y.; Salem, N.Jr.; Serhan, C.N.; Smith, L.E. Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat. Med., 2007, 13, 868-873.
23. Cash, J.L.; Hart, R.; Russ, A.; Dixon, J.P.; Colledge, W.H.; Doran, J.; Hendrick, A.G.; Carlton, M.B.; Greaves, D.R. Synthetic chemerin-derived peptides suppress inflammation through ChemR23. J. Exp. Med., 2008, 205, 767-775.
24. Wittamer, V.; Franssen, J.D.; Vulcano, M.; Mirjolet, J.F.; Le Poul, E.; Migeotte, I.;, Brézillon, S.; Tyldesley, R.; Blanpain, C.; Detheux, M.; Mantovani, A.; Sozzani, S.; Vassart, G.; Parmentier, M.; Communi, D. Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J. Exp. Med., 2003, 198, 977-985.
25. Campbell, E.L.; Louis, N.A.; Tomassetti, S.E.; Canny, G.O.; Arita, M.; Serhan, C.N.; Colgan, S.P. Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution. FASEB J., 2007, 21, 3162-3170.
26. Sun, Y.P.; Oh, S.F.; Uddin, J.; Yang, R.; Gotlinger, K.; Campbell, E.; Colgan, S.P.; Petasis, N.A.; Serhan, C.N. Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. J. Biol. Chem., 2007, 282, 9323-9334.
27. Bannenberg, G.L.; Chiang, N.; Ariel, A.; Arita, M.; Tjonahen, E.; Gotlinger, K.H.; Hong, S.; Serhan, C.N. Molecular circuits of resolution: formation and actions of resolvins and protectins. J. Immunol., 2005, 174, 4345-4355.
28. Kim, T.H.; Kim, G.D.; Jin, Y.H.; Park, Y.S.; Park, C.S. Omega-3 fatty acid-derived mediator, Resolvin E1, ameliorates 2,4-dinitrofluorobenzene-induced atopic dermatitis in NC/Nga mice. Int. Immunopharmacol., 2012, 14, 384-391.
29. Haworth, O.; Cernadas, M.; Yang, R.; Serhan, C.N.; Levy, B.D. Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation. Nat. Immunol., 2008, 9, 873-879.
30. Haworth, O.; Cernadas, M.; Levy, B.D. NK cells are effectors for resolvin e1 in the timely resolution of allergic airway inflammation. J. Immunol., 2011, 186, 6129-6135.
31. Arita, M.; Yoshida, M.; Hong, S.; Tjonahen, E.; Glickman, J.N.; Petasis, N.A.; Blumberg, R.S.; Serhan, C.N. Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc. Natl. Acad. Sci. U.S.A., 2005, 102, 7671-7676.
32. El Kebir, D.; Gjorstrup, P.; Filep, J.G. Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation. Proc. Natl. Acad. Sci. U. S. A., 2012, 109, 14983-14988.
33. Seki, H.; Fukunaga, K.; Arita, M.; Arai, H.; Nakanishi, H.; Taguchi, R.; Miyasho, T.; Takamiya, R.; Asano, K.; Ishizaka, A.; Takeda, J.;, Levy, B.D. The anti-inflammatory and proresolving mediator resolvin E1 protects mice from bacterial pneumonia and acute lung injury. J. Immunol., 2010, 184, 836-843.
34. Hasturk, H.; Kantarci, A.; Ohira, T.; Arita, M.; Ebrahimi, N.; Chiang, N.; Petasis, N.A.; Levy, B.D.; Serhan, C.N.; Van Dyke, T.E. RvE1 protects from local inflammation and osteoclast-mediated bone destruction in periodontitis. FASEB J., 2006, 20, 401-403.
35. Fredman, G.; Oh, S.F.; Ayilavarapu, S.; Hasturk, H.; Serhan, C.N.; Van Dyke, T.E. Impaired phagocytosis in localized aggressive periodontitis: rescue by Resolvin E1. PLoS One, 2011, 6, e24422.
36. Rajasagi, N.K.; Reddy, P.B.; Suryawanshi, A.; Mulik, S.; Gjorstrup, P.; Rouse BT. Controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin E1. J. Immunol., 2011, 186, 1735-1746.
37. Oh, S.F.; Dona, M.; Fredman, G.; Krishnamoorthy, S.; Irimia, D.; Serhan, C.N. Resolvin E2 formation and impact in inflammation resolution. J. Immunol., 2012, 188, 4527-4534.
38. Tjonahen, E.; Oh, S.F.; Siegelman, J.; Elangovan, S.; Percarpio, K.B.; Hong, S.; Arita, M.; Serhan, C.N. Resolvin E2: identification and anti-inflammatory actions: pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis. Chem. Biol., 2006, 13, 1193-1202.
39. Norling, L.V.; Dalli, J.; Flower, R.J.; Serhan, C.N.; Perretti, M. Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions. Arterioscler. Thromb. Vasc. Biol., 2012, 32, 1970-1978.
40. Krishnamoorthy, S.; Recchiuti, A.; Chiang, N.; Fredman, G.; Serhan, C.N. Resolvin D1 receptor stereoselectivity and regulation of inflammation and prokk microRNAs. Am. J. Pathol., 2012, 180, 2018-2027.
41. Duffield, J.S.; Hong, S.; Vaidya, V.S.; Lu, Y.; Fredman, G.; Serhan, C.N.; Bonventre, J.V. Resolvin D series and protectin D1 mitigate acute kidney injury. J. Immunol., 2006, 177, 5902-5911.
42. Recchiuti, A.; Krishnamoorthy, S.; Fredman, G.; Chiang, N.; Serhan, C.N. MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits. FASEB J., 2011, 25, 544-560.
43. Titos, E.; Rius, B.; González-Périz, A.; López-Vicario, C.; Morán-Salvador, E.; Martínez-Clemente, M.; Arroyo, V.; Clària, J. Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype. J. Immunol., 2011, 187, 5408-5418.
44. Clària, J.; Dalli, J.; Yacoubian, S.; Gao, F.; Serhan, C.N. Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat. J. Immunol., 2012, 189, 2597-2605.
45. Tang, Y.; Zhang, M.J.; Hellmann, J.; Kosuri, M.; Bhatnagar, A.; Spite, M. Proresolution Therapy for the Treatment of Delayed Healing of Diabetic Wounds. Diabetes, 2013, 62, 618-627.
46. Spite, M.; Summers, L.; Porter, T.F.; Srivastava, S.; Bhatnagar, A.; Serhan, C.N. Resolvin D1 controls inflammation initiated by glutathione-lipid conjugates formed during oxidative stress. Br. J. Pharmacol., 2009, 158, 1062-1073.
47. Liao, Z.; Dong, J.; Wu, W.; Yang, T.; Wang, T.; Guo, L.; Chen, L.; Xu, D.; Wen, F. Resolvin D1 attenuates inflammation in lipopolysaccharide-induced acute lung injury through a process involving the PPARgamma/NF-kappaB pathway. Respir. Res., 2012, 13, 110.
48. Rogerio, A.P.; Haworth, O.; Croze, R.; Oh, S.F.; Uddin, M.; Carlo, T.; Pfeffer M.A.; Priluck, R.; Serhan, C.N.; Levy, B.D. Resolvin D1 and aspirin-triggered resolvin D1 promote resolution of allergic airways responses. J. Immunol., 2012, 189, 1983-1991.
49. Liu, G.; Fiala, M.; Mizwicki, M.T.; Sayre, J.; Magpantay, L.; Siani, A.; Mahanian, M.; Chattopadhyay, M.; La Cava, A.; Wiedau-Pazos, M. Neuronal phagocytosis by inflammatory macrophages in ALS spinal cord: inhibition of inflammation by resolvin D1. Am. J. Neurodegener. Dis., 2012, 1, 60-74.
50. Bento, A.F.; Claudino, R.F.; Dutra, R.C.; Marcon, R.; Calixto, J.B. Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice. J. Immunol., 2011, 187, 1957-1969.
51. Chiang, N.; Fredman, G.; Bäckhed, F.; Oh, S.F.; Vickery, T.; Schmidt, B.A.; Serhan, C.N. Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature, 2012, 484, 524-528.
52. Xu, Q.; Yaksh, T.L. A brief comparison of the pathophysiology of inflammatory versus neuropathic pain. Curr. Opin. Anaesthesiol., 2011, 24, 400-407.
53. Moriyama, T.; Higashi, T.; Togashi, K.; Iida, T.; Segi, E.; Sugimoto, Y.; Tominaga, T.; Narumiya, S.; Tominaga, M. Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins. Mol. Pain, 2005, 1, 3.
54. Binshtok, A.M.; Wang, H.; Zimmermann, K.; Amaya, F.; Vardeh, D.; Shi, L.; Brenner, G.J.; Ji, R.R.; Bean, B.P.; Woolf, C.J.; Samad, T.A. Nociceptors are interleukin-1beta sensors. J. Neurosci., 2008, 28, 14062-14073.
55. Jin, X.; Gereau, R.W. 4th. Acute p38-mediated modulation of tetrodotoxin-resistant sodium channels in mouse sensory neurons by tumor necrosis factor-alpha. J. Neurosci., 2006, 26, 246-255.
56. Schaible, H.G.; von Banchet, G.S.; Boettger, M.K.; Bräuer, R.; Gajda, M.; Richter, F.; Hensellek, S.; Brenn, D.; Natura, G. The role of proinflammatory cytokines in the generation and maintenance of joint pain. Ann. N. Y. Acad. Sci., 2010, 1193, 60-69.
57. Park, C.K.; Xu, Z.Z.; Liu, T.; Lü, N.; Serhan, C.N.; Ji, R.R. Resolvin D2 is a potent endogenous inhibitor for transient receptor potential subtype V1/A1, inflammatory pain, and spinal cord synaptic plasticity in mice: distinct roles of resolvin D1, D2, and E1. J. Neurosci., 2011, 31, 18433-18438.
58. Kawasaki, Y.; Zhang, L.; Cheng, J.K.; Ji, R.R. Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J. Neurosci., 2008, 28, 5189-5194.
59. Chuang, H.H.; Prescott, E.D.; Kong, H.; Shields, S.; Jordt, S.E.; Basbaum, A.I.; Chao, M.V.; Julius, D. Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature, 2001, 411, 957-962.
60. Bandell, M.; Story, G.M.; Hwang, S.W.; Viswanath, V.; Eid, S.R.; Petrus, M.J.; Earley, T.J.; Patapoutian, A. Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. Neuron, 2004, 41, 849-857.
61. Woolf, C.J.; Safieh-Garabedian, B.; Ma, Q.P.; Crilly, P.; Winter, J. Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity. Neuroscience, 1994, 62, 327-331.
62. Ji, R.R.; Samad, T.A.; Jin, S.X.; Schmoll, R.; Woolf, C.J. p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron, 2002, 36, 57-68.
63. Liu, T.; Xu, Z.Z.; Park, C.K.; Berta, T.; Ji, R.R. Toll-like receptor 7 mediates pruritus. Nat. Neurosci., 2010, 13, 1460-1462.
64. Diogenes, A.; Ferraz, C.C.; Akopian, A.N.; Henry, M.A.; Hargreaves, K.M.; LPS sensitizes TRPV1 via activation of TLR4 in trigeminal sensory neurons. J. Dent. Res., 2011, 90, 759-764.
65. Qi, J.; Buzas, K.; Fan, H.; Cohen, J.I.; Wang, K.; Mont, E.; Klinman, D.; Oppenheim, J.J.; Howard, O.M. Painful pathways induced by TLR stimulation of dorsal root ganglion neurons. J. Immunol., 2011, 186, 6417-6426.
66. Ji, R.R.; Suter, M.R. p38 MAPK, microglial signaling, and neuropathic pain. Mol. Pain, 2007, 3, 33.
67. Xu, Z.Z.; Berta, T.; Ji, R.R. Resolvin E1 Inhibits Neuropathic Pain and Spinal Cord Microglial Activation Following Peripheral Nerve Injury. J. Neuroimmune Pharmacol., 2012, 8(1), 37-41.
68. Svensson, C.I.; Zattoni, M.; Serhan, C.N. Lipoxins and aspirin-triggered lipoxin inhibit inflammatory pain processing. J. Exp. Med., 2007, 204, 245-252.
69. Serhan, C.N.; Dalli, J.; Karamnov, S.; Choi, A.; Park, C.K.; Xu, Z.Z.; Ji, R.R.; Zhu M.; Petasis, N.A. Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain. FASEB J., 2012, 26, 1755-1765.
70. Bang, S.; Yoo, S.; Yang, T.J.; Cho, H.; Hwang, S.W. 17(R)-Resolvin D1 specifically inhibits TRPV3 leading to peripheral antinociception. Br. J. Pharmacol., 2012, 165, 683-692.
71. Macpherson, L.J.; Xiao, B.; Kwan, K.Y.; Petrus, M.J.; Dubin, A.E.; Hwang, S.; Cravatt, B.; Corey, D.P.; Patapoutian, A. An ion channel essential for sensing chemical damage. J. Neurosci., 2007, 27, 11412-11415.
72. Krishnamoorthy, S.; Recchiuti, A.; Chiang, N.; Yacoubian, S.; Lee, C.H.; Yang, R.; Petasis, N.A.; Serhan, C.N. Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc. Natl. Acad. Sci. U.S.A., 2010, 107, 1660-1665.
73. Bang, S.; Yoo, S.; Oh, U.; Hwang, S.W. Endogenous lipid-derived ligands for sensory TRP ion channels and their pain modulation. Arch. Pharm. Res., 2010, 33, 1509-1520
74. Huang, L.; Wang, C.F.; Serhan, C.N.; Strichartz, G. Enduring prevention and transient reduction of postoperative pain by intrathecal resolvin D1. Pain, 2011, 152, 557-565.
75. Feng, Q.X.; Feng, F.; Feng, X.Y.; Li, S.J.; Wang, S.Q.; Liu, Z.X.; Zhang, X.J.; Zhao, Q.C.; Wang, W. Resolvin D1 reverses chronic pancreatitis-induced mechanical allodynia, phosphorylation of NMDA receptors, and cytokines expression in the thoracic spinal dorsal horn. BMC Gastroenterol., 2012, 12, 148.
76. Xu, Z.Z.; Ji, R.R. Resolvins are potent analgesics for arthritic pain. Br. J. Pharmacol., 2011, 162, 274-277.
77. Kasuga, K.; Yang, R.; Porter, T.F. Agrawal N, Petasis NA, Irimia D, Toner M, Serhan CN. Rapid appearance of resolvin precursors in inflammatory exudates: novel mechanisms in resolution., J. Immunol., 2008, 181, 8677-8687.
78. Kim, H.Y.; Spector, A.A.; Xiong, Z.M. A synaptogenic amide N-docosahexaenoylethanolamide promotes hippocampal development. Prostaglandins Other Lipid Mediat., 2011, 96, 114-120.
79. Kim, H.Y.; Spector, A.A. Synaptamide, endocannabinoid-like derivative of docosahexaenoic acid with cannabinoid-independent function. Prostaglandins Leukot. Essent. Fatty Acids, 2013, 88, 121-125.
80. van Maanen, M. A.; Stoof, S. P.; Larosa, G. J.; Vervoordeldonk, M. J.; Tak, P. P. Role of the cholinergic nervous system in rheumatoid arthritis: aggravation of arthritis in nicotinic acetylcholine receptor α7 subunit gene knockout mice. Ann. Rheum. Dis., 2010, 69, 1717-1723.
81. Cutolo, M.; Foppiani, L.; Minuto, F. Hypothalamic-pituitary-adrenal axis impairment in the pathogenesis of rheumatoid arthritis and polymyalgia rheumatica. J. Endocrinol. Invest., 2002, 25, 19-23.
82. Luangsay, S.; Wittamer, V.; Bondue, B.; De Henau, O.; Rouger, L.; Brait, M.; Franssen, J.D.; de Nadai, P.; Huaux, F.; Parmentier, M. Mouse ChemR23 is expressed in dendritic cell subsets and macrophages, and mediates an anti-inflammatory activity of chemerin in a lung disease model. J. Immunol., 2009, 183, 6489-6499.
83. Hartt, J.K.; Barish, G.; Murphy, P.M.; Gao, J.L. N-formylpeptides induce two distinct concentration optima for mouse neutrophil chemotaxis by differential interaction with two N-formylpeptide receptor (FPR) subtypes. Molecular characterization of FPR2, a second mouse neutrophil FPR. J. Exp. Med., 1999, 190, 741-747.
84. Odusanwo, O.; Chinthamani, S.; McCall, A.; Duffey, M.E.; Baker, O.J. Resolvin D1 prevents TNF-α-mediated disruption of salivary epithelial formation. Am. J. Physiol. Cell. Physiol., 2012, 302, C1331-1345.
85. Goldberg, R.J.; Katz, J. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain, 2007, 129, 210-223.
86. Oh, D.Y.; Talukdar, S.; Bae, E.J.; Imamura, T.; Morinaga, H.; Fan, W.; Li, P.; Lu, W.J.; Watkins, S.M.; Olefsky, J.M. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell, 2010, 142, 687-698.
87. Nakamoto, K.; Nishinaka, T.; Matsumoto, K.; Kasuya, F.; Mankura, M.; Koyama Y,; Tokuyama, S. Involvement of the long-chain fatty acid receptor GPR40 as a novel pain regulatory system. Brain Res., 2012, 1432, 74-83.
88. González-Périz, A.; Horrillo, R.; Ferré, N.; Gronert, K.; Dong, B.; Morán-Salvador, E.; Titos, E.; Martínez-Clemente, M.; López-Parra, M.; Arroyo, V.; Clària, J. Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB. J., 2009, 23, 1946-1957.
89. Patwardhan, A.M.; Scotland, P.E.; Akopian, A.N.; Hargreaves, K.M. Activation of TRPV1 in the spinal cord by oxidized linoleic acid metabolites contributes to inflammatory hyperalgesia. Proc. Natl. Acad. Sci. U. S. A., 2009, 106, 18820-18824.
90. Hwang, S.W.; Cho, H.; Kwak, J.; Lee, S.Y.; Kang, C.J.; Jung, J.; Cho, S.; Min, K.H.; Suh, Y.G.; Kim, D.; Oh, U. Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc. Natl. Acad. Sci. U. S. A., 2000, 97, 6155-6160.
91. Yoo, S.; Han, S.; Park, Y.S.; Lee, J.H.; Oh, U.; Hwang, S.W. Lipoxygenase inhibitors suppressed carrageenan-induced Fos-expression and inflammatory pain responses in the rat. Mol. Cells., 2009, 27, 417-422.
92. Leader, B.; Baca, Q.J.; Golan, D.E. Protein therapeutics: a summary and pharmacological classification. Nat. Rev. Drug Discov., 2008, 7, 21-39.
93. Ernst, B.; Magnani, J.L. From carbohydrate leads to glycomimetic drugs. Nat. Rev. Drug Discov., 2009, 8, 661-677.
94. Winkler, J.W.; Uddin, J.; Serhan, C.N.; Petasis, N.A. Stereocontrolled total synthesis of the potent anti-inflammatory and pro-resolving lipid mediator resolvin D3 and its aspirin-triggered 17R-epimer. Org. Lett., 2013, 15, 1424-1427.
95. Arita, M.; Oh, S.F.; Chonan, T.; Hong, S.; Elangovan, S.; Sun Y.P.; Uddin, J.; Petasis, N.A.; Serhan, C.N. Metabolic inactivation of resolvin E1 and stabilization of its anti-inflammatory actions. J. Biol. Chem., 2006, 281, 22847-22854.
96. Hong, S.; Porter, T.F.; Lu, Y.; Oh, S.F.; Pillai, P.S.; Serhan, C.N. Resolvin E1 metabolome in local inactivation during inflammation-resolution. J. Immunol., 2008, 180, 3512-3519.
97. Yaksh, T.L.; Rudy, T.A. Analgesia mediated by a direct spinal action of narcotics. Science, 1976, 192, 1357-1358.
98. Chan, M. M.-Y.; Moore, A. R. Resolution of inflammation in murine autoimmune arthritis is disrupted by cyclooxygenase-2 inhibition and restored by prostaglandin E2-mediated lipoxin A4 production. J. Immunol., 2010, 184, 6418-6426.
99. Gilroy, D.W.; Colville-Nash, P.R.; Willis, D.; Chivers, J.; Paul-Clark, M.J.; Willoughby, D.A. Inducible cyclooxygenase may have anti-inflammatory properties. Nat. Med., 1999, 5, 698-701.
100. Yanes, O.; Clark, J.; Wong, D.M.; Patti, G.J.; Sánchez-Ruiz, A.; Benton, H.P.; Trauger, S.A.; Desponts, C.; Ding, S.; Siuzdak, G. Metabolic oxidation regulates embryonic stem cell differentiation. Nat. Chem. Biol., 2010, 6, 411-417.
101. Morris, T.; Stables, M.; Colville-Nash, P.; Newson, J.; Bellingan, G.; de Souza, P.M.; Gilroy, D.W. Dichotomy in duration and severity of acute inflammatory responses in humans arising from differentially expressed proresolution pathways. Proc. Natl. Acad. Sci. U S A., 2010, 107, 8842-8847.
102. Costigan, M.; Latremoliere, A.; Woolf, C.J. Analgesia by inhibiting tetrahydrobiopterin synthesis. Curr. Opin. Pharmacol., 2012, 12, 92-99.
103. Ebersberger, A.; Natura, G.; Eitner, A.; Halbhuber, K.J.; Rost, R.; Schaible, H.G. Effects of prostaglandin D2 on tetrodotoxin-resistant Na+ currents in DRG neurons of adult rat. Pain, 2011, 152, 1114-1126.
104. Kanda, H.; Kobayashi, K.; Yamanaka, H.; Noguchi, K. COX-1-dependent prostaglandin D2 in microglia contributes to neuropathic pain via DP2 receptor in spinal neurons. Glia, 2013, 61, 943-956.
105. Kohli, P.; Levy, B.D. Resolvins and protectins: mediating solutions to inflammation. Br. J. Pharmacol., 2009, 158, 960-971.